相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency
Susannah I. Thornhill et al.
MOLECULAR THERAPY (2008)
NOTCH1 mutation can be an early, prenatal genetic event in T-ALL
Minenori Eguchi-Ishimae et al.
BLOOD (2008)
Notch-1 mutations are secondary events in some patients with T-Cell acute lymphoblastic leukemia
Marc R. Mansour et al.
CLINICAL CANCER RESEARCH (2007)
High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR)
Schmidt Manfred et al.
NATURE METHODS (2007)
Hot spots of retroviral integration in human CD34+ hematopoietic cells
Claudia Cattoglio et al.
BLOOD (2007)
Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells
Fang Zhang et al.
BLOOD (2007)
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo
Kerstin Schwarzwaelder et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy
Annette Deichmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Exploration, normalization, and genotype calls of high-density oligonucleotide SNP array data
Benilton Carvalho et al.
BIOSTATISTICS (2007)
Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity
Ute Modlich et al.
BLOOD (2006)
Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning
H. Bobby Gaspar et al.
MOLECULAR THERAPY (2006)
Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy
Yan Shou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes
Michael J. Malecki et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia
C Grabher et al.
NATURE REVIEWS CANCER (2006)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
Activating Notch1 mutations in mouse models of T-ALL
J O'Neil et al.
BLOOD (2006)
The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion
CH Nam et al.
MOLECULAR THERAPY (2006)
Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia
FW van Delft et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling
WA Dik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Interleukin-7 in T-cell acute lymphoblastic leukemia: An extrinsic factor supporting leukemogenesis?
JT Barata et al.
LEUKEMIA & LYMPHOMA (2005)
Gene therapy insertional mutagenesis insights
UP Davé et al.
SCIENCE (2004)
Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences
RS Mitchell et al.
PLOS BIOLOGY (2004)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
HB Gaspar et al.
LANCET (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Transcription start regions in the human genome are favored targets for MLV integration
XL Wu et al.
SCIENCE (2003)
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
A Aiuti et al.
SCIENCE (2002)
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement
A Aiuti et al.
NATURE MEDICINE (2002)
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
V(D)J-mediated translocations in lymphoid neoplasms: A functional assessment of genomic instability by cryptic sites
R Marculescu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART)
DJS King et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)
分享论文
